Reposting from YMB. This sounds authentic and sincere to
Reposting from YMB. This sounds authentic and sincere to me.
Joe 6 minutes ago
As some of you know I am a physician and head of a large anesthesia group of one of the largest medical systems in Mississippi.
Unlike almost everyone on this board,I actually have used this drug on two patients. My experience is both sobering and extremely hopeful.
Early in December my 88 year old mother in law contracted Covid and by December 4th was hospitalized with it. She deteriorated very quickly and by December 8th was struggling to breath despite the latest in SOC which included Remdisivir and Decadron. I had already had Covid and was staying with her that night and contacted the company for a compassionate dose of LL to give to her. Unbelievably Nader and Scott Kelly helped me go through the legal hoops snd I had the drug here by December 10. Unfortunately my mother in law had further deteriorated and her inflammatory markers were out of the viable range. She received her first dose but died the next day.
I kept the second dose in the fridge and sure enough last week my favorite OR pharmacist became very ill with Covid and went to the ER, received IV decadron, Remdisivir and antibiotics for superinfection snd sent home on oxygen because our hospital is full. Her lungs showed pneumonia and her sats on oxygen were 90-91 percent. As a physician in Mississippi I explained the risk benefits of an experimental drug and she agreed to receive the LL. She actually did worse the following day but I had read that it takes 72 hours to take effect. I was alarmed though early on as I’ve seen multiple patients die within days of the condition she was in and if those patients did make it it was weeks snd months of pulmonary and other organ disfunction associated with their survival. However, at the 72 hour mark she quit needing breathing treatments and the fever broke. By hour 48 she just felt tired snd her cough was largely gone. It was really like a death blanket was taken off of her. I’m sitting here writing this still in awe of what just happened. She’s alive and going to be fine with no long term effects.. I know this is just observational and in no way can be used to change a practice, but by God I’m convinced the CD12 data will be off the charts positive and soon I’ll be able to give it to all my serious and critical patients if there is enough left.
Cheers to the end of 2020.
23
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Breaking New Ground: Boeing 737-10 Certified Well, the folks at Boeing must be popping champagne, because the U.S. Federal Aviation Administration (FAA) just handed them the golden ticket: certification for the brand spankin' new Boeing 737-10. This ain't your average paper-pushing approval. We're talking nearly 1,000 test flights and what seems like a mountain of safety...
Continue Reading
Fluence Energy in Hot Water: Class Action Alert What a time to be catching the news on Fluence Energy, Inc. (NASDAQ: FLNC), a company that seemed like it was on the verge of taking the market by storm. But instead of riding high, they’re stuck in the mud, dealing with a securities class action lawsuit. This comes after a relentless punch to their market cap—about $3...
Continue Reading
A Shake-Up in AI Infrastructure: ASUS Steps In Who's ready for a seismic shift in AI tech? ASUS popped out the gate with a big reveal at the NVIDIA GTC Berlin 2026, showcasing its new arsenal of AI systems built on NVIDIA's HGX Rubin NVL8. These aren't your average rigs either; they're set to hit the market in Q4 2026 with configurations that cater to everything from AI...
Continue Reading
Alignment or Deception: The M&A Alarm Bells Investors, strap in, because the world of mergers and acquisitions is lighting up like a pinball machine, and today's spotlight's on Varex Imaging Corporation (NASDAQ: VREX), MarineMax (NYSE: HZO), and Synaptics Incorporated (NASDAQ: SYNA). Halper Sadeh LLC, known for their tenacity in championing shareholder rights, has brought...
Continue Reading
NAPCO's New Showcase at ISC East 2026 Let's dive into NAPCO Security Technologies' latest development, because these folks are taking the stage at the ISC East 2026, one of the big kahunas in security trade shows. Happening on November 4th and 5th at the Jacob Javits Center, the booth near the main entrance will be the place to catch the latest from this New York outfit,...
Continue Reading
Ecopetrol: A Rock in Turbulent Waters If you’re looking for a boulder in a sea of pebbles, Ecopetrol’s got the heft. When Fitch Ratings gives a thumbs-up, you best believe they mean it. On October 20, 2026, the rating agency confirmed Ecopetrol’s global credit rating at BB, with a stable outlook, but it’s how they got there that counts. Their standalone credit...
Continue Reading
A Shift in Rehab Therapy Alright, it's not every day you see a seismic shift in the world of rehab therapy. Limber Health just dropped the mic with their brand-new Recovery Forecast. Built on the heftiest risk-adjusted patient outcomes database in the game, this tool aims to replace those old-school, single-snapshot forecasts with a full 90-day predictive outlook. If you...
Continue Reading
Diversifying with Property Restoration Stroll through any franchise expo and the buzzwords are all there: growth, opportunity, scalability. But in the crowded room of glittery pitches, the ones really shaking things up are those that go beyond the razzle-dazzle—brands like PuroClean that stick it to the competition with real, boots-on-the-ground expansion. The...
Continue Reading
Investigating Robotic Mower Imports Some news for Husqvarna Group today, where the European Commission dropped a disclosure that’s sure to keep the execs on their toes. Yeah, we’re talking about that anti-dumping investigation, where the EU’s been eyeing imports of robotic mowers from China. Now, this isn’t the final bell—just another step in an ongoing...
Continue Reading
Network Brainiacs Steps into Maryland Territory If you're in the tech services game, expansion stories are the bread and butter of this business. Network Brainiacs, a seasoned veteran in the managed IT and cybersecurity sectors, has taken their first big step into Maryland by acquiring Computer Enhancement Systems (CES), a notable player in the field, as of September 1,...
Continue Reading
Top 5 Most Recently Viewed Articles
Grasping the Shift Toward Lower Interest Rates The Federal Reserve's move towards a more accommodating monetary policy is making significant waves in the investment world. Investors are now faced with important decisions about how this change will affect different asset classes, especially equities and fixed income. Historically, stock markets tend to perform well after...
Continue Reading
Castle Biosciences Set to Showcase at Upcoming Healthcare Conference Castle Biosciences, Inc. (Nasdaq: CSTL), based in Friendswood, Texas, is gearing up to present at a significant healthcare event. The company is known for its innovative diagnostic tests aimed at enhancing patient care, reflecting its commitment to improving health outcomes through science. Scheduled for...
Continue Reading
Exploring the Growth of the Lutein Market The global lutein market, currently valued at USD 392.1 million, is on a rapid growth trajectory. By 2034, it is anticipated to soar to USD 663.5 million, propelled by a compound annual growth rate (CAGR) of 5.4%. This significant increase reflects the rising awareness and demand in various sectors, particularly within wellness...
Continue Reading
Climbing and Conversations with Tommy Caldwell There’s not a lot that can make a hard-nosed stock trader pause, but when Tommy Caldwell talks resilience after losing a finger and scaling Scimitar with his son, even the most seasoned might stop and listen. Beside Lake Tahoe, Caldwell's recent climb was more than just a trek with his son Fitz; it was a showcase of his...
Continue Reading
Introduction to New Leadership at Newtek Merchant Solutions NewtekOne, Inc. (NASDAQ: NEWT), known for its comprehensive business solutions, is thrilled to announce the appointment of John O'Connor as the Chief Revenue Officer for its payment processing subsidiary, Newtek Merchant Solutions (NMS). This strategic hiring aims to bolster NMS's position in the marketplace by...
Continue Reading